Diagnostic and Treatment Orders for Secondary Hypertension

Initial Screening and Diagnosis

• The American College of Cardiology recommends screening all patients with confirmed hypertension using plasma aldosterone-to-renin ratio (ARR), as primary aldosteronism is the most common treatable cause of resistant hypertension (8-20% of cases) 1, 2
• The European Society of Cardiology recommends plasma aldosterone-to-renin ratio (ARR) for all adults with confirmed hypertension (Class IIa recommendation) 2
• Serum electrolytes (sodium, potassium) should be checked, as hypokalemia strongly suggests primary aldosteronism 1, 2
• Serum creatinine and estimated glomerular filtration rate (eGFR) should be checked 1, 2
• Fasting blood glucose or HbA1c should be checked 3, 2
• Urinalysis with microscopy should be performed to look for blood, protein, and casts suggesting renal parenchymal disease 3, 2
• Urinary albumin-to-creatinine ratio should be checked 2
• Thyroid-stimulating hormone (TSH) should be checked 2
• Fasting lipid panel should be checked 3
• 12-lead electrocardiogram should be performed to assess for left ventricular hypertrophy and strain patterns 3, 2

Targeted Investigations Based on Clinical Clues

• The American College of Cardiology recommends ordering renovascular disease workup when patient presents with abrupt onset or sudden worsening of previously controlled hypertension, flash pulmonary edema, serum creatinine increase ≥50% within one week of starting ACE inhibitor or ARB, severe hypertension with unilateral smaller kidney or kidney size difference >1.5 cm, or abdominal systolic-diastolic bruit on examination 1, 2, 4
• The European Society of Cardiology recommends ordering pheochromocytoma workup when patient presents with episodic symptoms, labile or paroxysmal hypertension, hypertensive crisis during anesthesia or surgery, or family history of pheochromocytoma or multiple endocrine neoplasia 1, 2
• The American College of Cardiology recommends ordering sleep apnea evaluation when patient presents with resistant hypertension, snoring, witnessed apneas, daytime sleepiness, obesity (BMI >30) with Mallampati class III-IV airway, or non-dipping nocturnal blood pressure pattern on ambulatory monitoring 1, 2
• The European Society of Cardiology recommends ordering Cushing syndrome workup when patient presents with central obesity with thin extremities, purple striae, easy bruising, proximal muscle weakness, moon facies, buffalo hump, or supraclavicular fat pads 3, 2

Confirmatory Testing for Primary Aldosteronism

• The American College of Cardiology recommends confirmatory tests such as oral sodium loading test with 24-hour urine aldosterone or IV saline infusion test with plasma aldosterone at 4 hours when ARR is positive (ratio >20 with elevated aldosterone and suppressed renin) 1, 2, 5
• The American College of Cardiology recommends localization studies such as adrenal CT scan or adrenal vein sampling after biochemical confirmation 1, 2

Treatment Orders Based on Specific Diagnosis

• The American College of Cardiology recommends unilateral laparoscopic adrenalectomy for unilateral primary aldosteronism and spironolactone 50-100 mg daily for bilateral primary aldosteronism 2, 4, 5
• The European Society of Cardiology recommends medical therapy as the preferred treatment for atherosclerotic renal artery stenosis, with optimization of cardiovascular risk management, statin therapy, antiplatelet therapy, and ACE inhibitor or ARB 1, 2, 5
• The American College of Cardiology recommends percutaneous transluminal renal angioplasty without stenting for fibromuscular dysplasia 2, 5
• The American College of Cardiology recommends continuous positive airway pressure (CPAP) therapy as the first-line treatment for moderate to severe obstructive sleep apnea (OSA) 2, 5
• The European Society of Cardiology recommends alpha-blockade with phenoxybenzamine and beta-blockade for pre-operative preparation of pheochromocytoma, followed by surgical resection 1, 2, 5

Resistant Hypertension Protocol

• The American College of Cardiology recommends optimizing the current regimen, adding a fourth-line agent such as spironolactone, and considering alternative fourth-line agents such as doxazosin or bisoprolol for resistant hypertension 2, 4, 5

Critical Pitfalls to Avoid

• The American College of Cardiology recommends avoiding the combination of two RAS blockers (ACE inhibitor + ARB) due to increased risk of hyperkalemia, hypotension, and acute kidney injury without additional benefit 2
• The European Society of Cardiology recommends avoiding expensive imaging (CT, MRI, angiography) before completing basic laboratory screening 2
• The American College of Cardiology recommends recognizing that 5-10% of all hypertensive patients have secondary causes, increasing to 10-20% in resistant cases, and maintaining a high index of suspicion 4

Guidelines for Diagnosis and Management of Secondary Hyperaldosteronism with Elevated Renin

Diagnostic Criteria and Initial Evaluation

• Elevated renin together with high aldosterone signals secondary hyperaldosteronism, most often due to renovascular disease, and mandates urgent renal‑artery imaging (Doppler ultrasound or CT/MR angiography). 6, 7
• Resistant hypertension (BP > 140/90 mmHg on ≥ 3 antihypertensives, including a diuretic) occurs in 5 %–34 % of patients with renovascular disease. 6, 7
• Both plasma aldosterone and renin should be measured; absolute concentrations are more informative than the aldosterone‑to‑renin ratio when both are elevated. 8
• Serum potassium may be low (hypokalemia) or normal; hypokalemia supports a hyperaldosteronism diagnosis. 9, 8
• Baseline renal function (serum creatinine, eGFR) and urinary albumin‑to‑creatinine ratio are required to assess renal damage. 8

First‑Line Imaging

• Renal Doppler ultrasound is the recommended initial imaging modality for patients with high renin. 6, 7
• CT or MR renal angiography provides definitive visualization of renal‑artery stenosis and should follow an inconclusive or abnormal Doppler study. 8, 6, 7
• Imaging must be performed urgently in patients with abrupt/worsening hypertension, flash pulmonary edema, or a ≥ 50 % rise in creatinine after starting an ACE inhibitor or ARB. 7

Physical‑Exam Clues

• An abdominal systolic‑diastolic bruit suggests renovascular disease. 7
• Flash pulmonary edema (jugular venous distension, peripheral edema) indicates severe bilateral renal‑artery stenosis. 7
• Radio‑femoral pulse delay points toward aortic coarctation as an alternative cause of secondary hypertension. 7

Etiology‑Specific Management

Atherosclerotic Renal‑Artery Stenosis

• Renin‑angiotensin system (RAS) blockade (ACE inhibitor or ARB) is the first‑line therapy (Class I, Level A). 8
• Statin therapy and antiplatelet agents are recommended for cardiovascular risk reduction. 7
• Stenting may be considered for bilateral stenosis, flash pulmonary edema, or refractory hypertension despite optimal medical therapy. 9, 8, 6
• The CORAL trial demonstrated no benefit of routine stenting for unilateral atherosclerotic stenosis. 9, 8

Fibromuscular Dysplasia (FMD)

• Percutaneous transluminal renal angioplasty without stenting is the treatment of choice for FMD. 6, 7
• FMD is a systemic vascular disorder that can also involve carotid and other arteries. 6

General Therapeutic Strategies

• Monitor renal function closely after initiating RAS blockade; a ≥ 50 % creatinine increase within one week suggests bilateral stenosis or solitary‑kidney involvement. 7
• Add an aldosterone antagonist (spironolactone 50–100 mg daily or eplerenone) to control hyperaldosteronism when potassium ≤ 4.5 mmol/L and eGFR ≥ 45 mL/min/1.73 m². 6

Pitfalls to Avoid

• Failing to image the renal arteries in the presence of elevated renin is a critical diagnostic error. 6, 7
• Starting RAS blockade without creatinine monitoring in suspected bilateral stenosis can precipitate acute kidney injury. 7
• Overlooking medication‑induced hypertension (e.g., NSAIDs, decongestants, oral contraceptives) before extensive work‑up. 10

Referral Recommendations

• Refer patients with positive screening (elevated aldosterone + renin) for confirmatory renal angiography and possible intervention. 8
• Refer complex cases where diagnosis remains uncertain after initial work‑up. 8
• Refer for revascularization evaluation (stenting or angioplasty) when medical therapy fails or complications such as flash pulmonary edema develop. 9, 8, 6